Two posters presented at the 2025 European Hematology Association Congress support combination therapy with daratumumab, ...

During a live event, Samuel M. Rubinstein, MD, discussed the outcomes from the KarMMa-3 trial and real-world patients ...

Yelak Biru was diagnosed with multiple myeloma at 25 and given just a few years to live. Thirty years later, he's thriving.

During a live event, Konstantinos Sdrimas, MD, and community oncologists discussed patient concerns over CAR T-cell therapy ...

Johnson & Johnson announced today initial Phase 1 results of JNJ-79635322 (JNJ-5322), a novel investigational trispecific antibody (TsAb) in patients with relapsed or refractory multiple myeloma.

Oral presentation of CARTITUDE-1 study data showcases long-term outcomes after a single infusion of CARVYKTI ® with one-third of patients with relapsed/refractory multiple myeloma progression-free for ...

Get trusted information for every step of your journey. Multiple myeloma can be tricky. That’s because it sometimes has no symptoms. Or the signs look like other illnesses. What causes multiple ...

Stallergenes Greer, a global leader in allergy therapeutics, will present insightful scientific developments at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025, Glasgow ...

"I won't hold my breath, because most of my patients do relapse at some point, but I was really excited about this curve when ...

Diagnosed with incurable cancer, Jonathan Gluck reveals how two decades of uncertainty taught him to find resilience through ...

While older millennials currently have the the highest rates, researchers believe cases may continue to rise among younger generations.

Former professional wrestler Randy Mulkey is undergoing treatment for multiple myeloma, a rare blood cancer. He was half of the Mulkey Brothers tag team ...